Triple negative breast cancer (TNBC) is a subtype of breast cancer, with estrogen receptor,
human epidermal growth factor receptor 2 and progesterone receptor negative. TNBC is …

The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

The liver cancer has microenvironmental features such as low pH, M2 tumor-associated
macrophage enrichment, low oxygen, rich blood supply and susceptibility to hematotropic …

Lysine-deficient protein kinase-1 (WNK1) is critical for both embryonic angiogenesis and
tumor-induced angiogenesis. However, the downstream effectors of WNK1 during these …

The incidence of primary liver tumors, hepatocellular carcinoma (HCC), intrahepatic
cholangiocellular carcinoma (ICC), and combined HCC/ICC (cHCC/CC) is increasing. For …

To investigate efficacy and safety of hepatic arterial infusion chemotherapy combined with
lenvatinib (HAIC-Len) and HAIC alone for the treatment of advanced hepatocellular …

Lenvatinib plus transarterial chemoembolization (TACE) have become the first choice for
patients with hepatocellular carcinoma (HCC) that are unsuitable for TACE. Sorafenib plus …

Primary liver cancer is the sixth most common cause of cancer deaths in the United States
with hepatocellular carcinoma (HCC) representing approximately 75% of cases. 1 The most …

Background The use of regorafenib in the treatment of hepatocellular carcinoma (HCC) is
widespread. Albumin-Bilirubin (ALBI) has been shown to be a potential prognostic marker …

PURPOSE The purpose of this study was to analyze and compare the outcomes of
percutaneous microwave ablation (MWA) when used as a primary vs. secondary treatment …